Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Dipeptidyl Peptidase-4 Inhibitor Influences the Absorption of Intestine in Short Bowel Syndrome

NCT02653131 is registered in ClinicalTrials.gov with Stanley Dudrick's Memorial Hospital as lead sponsor.

NCT NCT02653131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02653131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Dipeptidyl Peptidase-4 Inhibitor Influences the Absorption of Intestine in Short Bowel Syndrome
Lead sponsor
Stanley Dudrick's Memorial Hospital
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2016
Completion date
April 30, 2020
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

short bowel syndrome